Breakthrough discovery on tau protein opens new paths for Alzheimer’s drug development Post author:admin Post published:February 11, 2025 Post category:uncategorized A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau. You Might Also Like Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models August 1, 2024 Study sheds light on impact of shyness on child language development October 13, 2023 Hamilton and Amabel James Center for AI and Human Health launches at Mount Sinai November 25, 2024
Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models August 1, 2024